D'Souza M F, Tooley M, Charlton J R
J R Coll Gen Pract. 1987 Jul;37(300):296-300.
A series of comparative trials on nine popular and pharmacologically distinct regimens for the treatment of hay fever was undertaken in the course of normal general practice in the pollen seasons of 1981-83. One hundred and forty doctors recruited 640 patients to assess the overall usefulness of the treatments on daily diaries. ;Usefulness' was scored on a linear analogue scale weighing up the degree of hay fever symptoms during treatment, side effects and ease of use of the preparation.The regimen with the highest overall usefulness score was beclomethasone diproprionate with sodium cromoglycate eye drops (Beconase and Opticrom). Although the score was not significantly higher than those for methylprednisolone acetate (Depo-Medrone), astemizole (Hismanal) or terfenadine (Triludan), Beconase/Opticrom scored significantly better than mequitazine (Primalan), chlorpheniramine maleate (Piriton), sodium cromoglycate nasal insufflation with xylometazoline/antazoline eye drops (Rynacrom and Otrivine-Antistin) and azatadine maleate (Optimine). Beconase/Opticrom was first in rank order with respect to all the other regimens for the treatment of both mild and severe hay fever. Dimethothiazine (Banistyl), also shown to be useful, has since been withdrawn from prescription.
在1981 - 1983年花粉季节的正常全科医疗过程中,对九种治疗花粉热的常用且药理性质不同的疗法进行了一系列对比试验。140名医生招募了640名患者,通过日常日记来评估这些疗法的总体效用。“效用”通过线性模拟量表评分,综合考量治疗期间花粉热症状的程度、副作用以及制剂的易用性。总体效用得分最高的疗法是丙酸倍氯米松联合色甘酸钠滴眼液(必可酮和奥洛他定)。虽然该得分并不显著高于醋酸甲泼尼龙(得宝松)、阿司咪唑(息斯敏)或特非那定(敏迪),但必可酮/奥洛他定的得分显著高于美喹他嗪(普瑞马林)、马来酸氯苯那敏(扑尔敏)、色甘酸钠鼻喷雾剂联合赛洛唑啉/安他唑啉滴眼液(雷诺考特和诺通 - 安他唑啉)以及马来酸氮卓斯汀(奥普明)。在必可酮/奥洛他定与所有其他治疗轻度和重度花粉热的疗法的排序中,它位列第一。二甲噻嗪(班尼司特)也显示出有效,但此后已退出处方用药。